Research programme: intron fusion proteins - SymphogenAlternative Names: Dimercept; IFP/SCAN; Intron Fusion Proteins
Latest Information Update: 13 Feb 2009
At a glance
- Originator Oregon Health & Science University; Receptor BioLogix
- Developer Symphogen
- Mechanism of Action Angiogenesis inhibitors; Epidermal growth factor receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Preclinical Autoimmune disorders; Cancer; Inflammation; Metabolic disorders